Academic-industrial collaboration in the development of the first angiotensin receptor blocker: neprilysin inhibitor in the treatment of heart failure: Table 1

Eugene Braunwald

doi:10.1093/eurheartj/ehw055

Academic-industrial collaboration in the development of the first angiotensin receptor blocker: neprilysin inhibitor in the treatment of heart failure: Table 1

European Heart Journal ◽

10.1093/eurheartj/ehw055 ◽

2016 ◽

Vol 37 (9) ◽

pp. 745-746 ◽

Cited By ~ 3

Author(s):

Eugene Braunwald

Keyword(s):

Heart Failure ◽

Angiotensin Receptor Blocker ◽

Receptor Blocker ◽

Angiotensin Receptor ◽

Neprilysin Inhibitor ◽

Industrial Collaboration

Get full-text (via PubEx)

Utility of natriuretic peptides to assess and manage patients with heart failure receiving angiotensin receptor blocker/neprilysin inhibitor therapy

Postgraduate Medicine ◽

10.1080/00325481.2018.1440873 ◽

2018 ◽

Vol 130 (3) ◽

pp. 299-307 ◽

Cited By ~ 11

Author(s):

Alan S. Maisel ◽

Lori B. Daniels ◽

Inder S. Anand ◽

Peter A. McCullough ◽

Sheryl L. Chow

Keyword(s):

Heart Failure ◽

Natriuretic Peptides ◽

Angiotensin Receptor Blocker ◽

Inhibitor Therapy ◽

Receptor Blocker ◽

Angiotensin Receptor ◽

Neprilysin Inhibitor ◽

Patients With Heart Failure

Get full-text (via PubEx)

Efficacy of sodium-glucose cotransporter-2 inhibitors in heart failure patients treated with dual angiotensin receptor blocker-neprilysin inhibitor: an updated meta-analysis

European Heart Journal - Cardiovascular Pharmacotherapy ◽

10.1093/ehjcvp/pvab034 ◽

2021 ◽

Author(s):

Massimiliano Camilli ◽

Marco Lombardi ◽

Juan Guido Chiabrando ◽

Marco Giuseppe Del Buono ◽

Rocco Antonio Montone ◽

...

Keyword(s):

Heart Failure ◽

Angiotensin Receptor Blocker ◽

Meta Analysis ◽

Receptor Blocker ◽

Angiotensin Receptor ◽

Heart Failure Patients ◽

Sodium Glucose Cotransporter ◽

Neprilysin Inhibitor

Get full-text (via PubEx)

Efficacy of Sodium-Glucose Cotransporter-2 inhibitors in heart failure patients treated with dual angiotensin receptor blocker-neprilysin inhibitor: An updated meta-analysis

Annals of Medicine and Surgery ◽

10.1016/j.amsu.2021.102796 ◽

2021 ◽

Vol 70 ◽

pp. 102796

Author(s):

Naser Yamani ◽

Fahd Niaz Shaikh ◽

Saba Sarfraz ◽

Haider Kamal Khan ◽

Muhammad Fahad Wasim ◽

...

Keyword(s):

Heart Failure ◽

Angiotensin Receptor Blocker ◽

Meta Analysis ◽

Receptor Blocker ◽

Angiotensin Receptor ◽

Heart Failure Patients ◽

Sodium Glucose Cotransporter ◽

Neprilysin Inhibitor

Get full-text (via PubEx)

555 Indirect comparison of the effects of adding an aldosterone antagonist or an angiotensin receptor blocker in severe heart failure: new data from the CHARM-Added trial

European Journal of Heart Failure Supplements ◽

10.1016/s1567-4215(06)80352-8 ◽

2006 ◽

Vol 5 (1) ◽

pp. 124-124

Author(s):

R WEIR ◽

J MCMURRAY ◽

C GRANGER ◽

B OLOFSSON ◽

J OSTERGREN ◽

...

Keyword(s):

Heart Failure ◽

Angiotensin Receptor Blocker ◽

Indirect Comparison ◽

Severe Heart Failure ◽

Receptor Blocker ◽

Angiotensin Receptor ◽

Aldosterone Antagonist

Get full-text (via PubEx)

Use of angiotensin receptor blocker is associated with improved 1 year mortality in heart failure with mid‐range ejection fraction

ESC Heart Failure ◽

10.1002/ehf2.13229 ◽

2021 ◽

Vol 8 (2) ◽

pp. 1438-1445

Author(s):

Bin Wang ◽

Lihua Zhang ◽

Shuang Hu ◽

Xueke Bai ◽

Xi Li ◽

...

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Angiotensin Receptor Blocker ◽

Receptor Blocker ◽

Angiotensin Receptor

Get full-text (via PubEx)

Effects of Combination of ACE Inhibitor and Angiotensin Receptor Blocker on Cardiac Remodeling, Cardiac Function, and Survival in Rat Heart Failure

Circulation ◽

10.1161/01.cir.103.1.148 ◽

2001 ◽

Vol 103 (1) ◽

pp. 148-154 ◽

Cited By ~ 106

Author(s):

Shokei Kim ◽

Minoru Yoshiyama ◽

Yasukatsu Izumi ◽

Hitomi Kawano ◽

Manabu Kimoto ◽

...

Keyword(s):

Heart Failure ◽

Cardiac Function ◽

Cardiac Remodeling ◽

Rat Heart ◽

Angiotensin Receptor Blocker ◽

Ace Inhibitor ◽

Receptor Blocker ◽

Angiotensin Receptor

Get full-text (via PubEx)

Effect of the Angiotensin Receptor Blocker Valsartan on Morbidity and Mortality in Heart Failure: the Valsartan Heart Failure Trial (Val-HeFT)

Circulation ◽

10.1161/01.cir.102.21.2672-b ◽

2000 ◽

Vol 102 (21) ◽

pp. 2672-2672 ◽

Cited By ~ 14

Author(s):

Jay N. Cohn ◽

Gianni Tognoni

Keyword(s):

Heart Failure ◽

Angiotensin Receptor Blocker ◽

Morbidity And Mortality ◽

Receptor Blocker ◽

Angiotensin Receptor ◽

Heart Failure Trial

Get full-text (via PubEx)

Race and association of angiotensin converting enzyme/angiotensin receptor blocker exposure with outcome in heart failure

Journal of Cardiovascular Medicine ◽

10.2459/jcm.0000000000000091 ◽

2015 ◽

Vol 16 (9) ◽

pp. 591-596 ◽

Cited By ~ 5

Author(s):

Mostafa El-Refai ◽

Tara Hrobowski ◽

Edward L. Peterson ◽

Karen Wells ◽

John A. Spertus ◽

...

Keyword(s):

Heart Failure ◽

Angiotensin Converting Enzyme ◽

Angiotensin Receptor Blocker ◽

Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Receptor

Get full-text (via PubEx)

Effect of Combination Angiotensin-Converting Enzyme and Angiotensin Receptor Blocker Therapy on Heart Failure Mortality and Morbidity

The American Journal of Cardiology ◽

10.1016/j.amjcard.2007.10.013 ◽

2008 ◽

Vol 101 (5) ◽

pp. 744-745

Author(s):

John R. Kapoor

Keyword(s):

Heart Failure ◽

Angiotensin Converting Enzyme ◽

Angiotensin Receptor Blocker ◽

Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Blocker Therapy ◽

Mortality And Morbidity

Get full-text (via PubEx)

Predicting adverse events during angiotensin receptor blocker treatment in heart failure: results from the HEAAL trial

European Journal of Heart Failure ◽

10.1093/eurjhf/hfs145 ◽

2012 ◽

Vol 14 (12) ◽

pp. 1401-1409 ◽

Cited By ~ 21

Author(s):

Michael S. Kiernan ◽

Deborah Wentworth ◽

Gary Francis ◽

Felipe A. Martinez ◽

Kenneth Dickstein ◽

...

Keyword(s):

Heart Failure ◽

Adverse Events ◽

Angiotensin Receptor Blocker ◽

Receptor Blocker ◽

Angiotensin Receptor

Get full-text (via PubEx)